Neurological insights on two siblings with GM3 synthase deficiency due to novel compound heterozygous ST3GAL5 variants
Brain and Development · 2023
DOI: 10.1016/j.braindev.2023.01.002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain and Development, 2023. Verfasst von Shiena Watanabe und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Child Neurology, National Center Hospital, National Center of Neurology and Psychiatry, Japan. Hauptthemen laut MEDLINE: Dyskinesias, Siblings. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 24 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: ST3GAL5 encodes GM3 synthase (ST3 beta-galactoside alpha-2,3-sialyltransferase 5; ST3GAL5), which synthesizes GM3 by transferring sialic acid to lactosylceramide. GM3, a sialic acid-containing glycosphingolipid known as ganglioside, is a precursor to the biosynthesis of various more complex gangliosides that are active in the brain. Biallelic variants in ST3GAL5 cause GM3 synthase deficiency (GM3SD), a rare congenital disorder of glycosylation. GM3SD was first identified in the Amish population in 2004. CASE: We report two siblings diagnosed with GM3SD due to novel compound heterozygous ST3GAL5 variants. The novel ST3GAL5 variants, detected by whole-exome sequencing in the patients, were confirmed to be pathogenic by GM3 synthase assay. The clinical courses of these patients, which began in infancy with irritability and growth failure, followed by developmental delay and hearing loss, were consistent with previous case reports of GM3SD. The older sibling underwent deep brain stimulation for severe involuntary movements at the age of 9 years. The younger sibling suffered from acute encephalopathy at the age of 9 months and subsequently developed refractory epilepsy. DISCUSSION: Reports of GM3SD outside the Amish population are rare, and whole-exome sequencing may be required to diagnose GM3SD in non-Amish patients. Since an effective treatment for GM3SD has not yet been established, we might select deep brain stimulation as a symptomatic treatment for involuntary movements in GM3SD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Child Neurology, National Center Hospital, National Center of Neurology and Psychiatry, Japan.
- Department of Human Genetics, Yokohama City University Graduate School of Medicine, Japan.
- Department of Child Neurology, National Center Hospital, National Center of Neurology and Psychiatry, Japan. Electronic address: nakagawa@ncnp.go.jp.
- Division of Glycopathology, Institute of Molecular Biomembrane and Glycobiology, Tohoku Medical and Pharmaceutical University, Japan.
- Center for Medical Education, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Japan.
- Department of Human Genetics, Yokohama City University Graduate School of Medicine, Japan; Division of Neurology, Department of Internal Medicine, St. Marianna University School of Medicine, Japan.
Zitieren
APA
Watanabe, S., Lei, M., Nakagawa, E., Takeshita, E., Inamori, K. I., Shishido, F., Sasaki, M., Mitsuhashi, S., Matsumoto, N., Kimura, Y., Iwasaki, M., Takahashi, Y., Mizusawa, H., Migita, O., Ohno, I., & Inokuchi, J. I. (2023). Neurological insights on two siblings with GM3 synthase deficiency due to novel compound heterozygous ST3GAL5 variants. Brain and Development. https://doi.org/10.1016/j.braindev.2023.01.002
Vancouver
Watanabe S, Lei M, Nakagawa E, Takeshita E, Inamori KI, Shishido F, et al. Neurological insights on two siblings with GM3 synthase deficiency due to novel compound heterozygous ST3GAL5 variants. Brain and Development. 2023. doi:10.1016/j.braindev.2023.01.002
BibTeX
@article{Watanabe2023,
author = {Watanabe, Shiena and Lei, Ming and Nakagawa, Eiji and Takeshita, Eri and Inamori, Kei-Ichiro and Shishido, Fumi and Sasaki, Masayuki and Mitsuhashi, Satomi and Matsumoto, Naomichi and Kimura, Yuiko and Iwasaki, Masaki and Takahashi, Yuji and Mizusawa, Hidehiro and Migita, Ohsuke and Ohno, Isao and Inokuchi, Jin-Ichi},
title = {Neurological insights on two siblings with GM3 synthase deficiency due to novel compound heterozygous ST3GAL5 variants},
journal = {Brain and Development},
year = {2023},
doi = {10.1016/j.braindev.2023.01.002}
}
EUVIMED